Most Recent

image: Another Role for ApoE?

Another Role for ApoE?

By | January 20, 2016

Key Alzheimer’s disease–related protein may be a transcriptional regulator.

3 Comments

image: Shire to Buy Baxalta for $32 Billion

Shire to Buy Baxalta for $32 Billion

By | January 12, 2016

The Dublin-based pharma giant is set to acquire Baxalta, an Illinois-based Baxter spinoff, expanding its rare disease drug portfolio.

0 Comments

image: Thermo Fisher to Acquire Affymetrix

Thermo Fisher to Acquire Affymetrix

By | January 11, 2016

The boards of both companies have agreed to a $1.3 billion deal, which is subject to Affymetrix shareholder approval.

0 Comments

image: How Multicellularity Arose

How Multicellularity Arose

By | January 11, 2016

Researchers identify a molecule that may have been key to the surprisingly common transition from single-celled ancestors to today’s complex, multicellular organisms. 

0 Comments

image: Molecular Fingerprint Predicts Flu Shot Response

Molecular Fingerprint Predicts Flu Shot Response

By | January 4, 2016

A gene-expression signature correlates with a person’s likelihood of experiencing adverse events after receiving a seasonal flu vaccine, scientists show. 

0 Comments

image: Fearless about Folding

Fearless about Folding

By | January 1, 2016

Susan Lindquist has never shied away from letting her curiosity guide her research career.

1 Comment

image: Master Folder

Master Folder

By | January 1, 2016

Meet Susan Lindquist, the MIT biologist who has won numerous accolades for her research on protein folding.

0 Comments

image: Smooth Move

Smooth Move

By | January 1, 2016

In the mouse lung, hardening of a blood vessel can result from just a single progenitor cell forming new smooth muscle.

0 Comments

image: Discoverer of G Proteins Dies

Discoverer of G Proteins Dies

By | December 29, 2015

Nobel laureate Alfred Gilman has passed away at age 74.

0 Comments

image: Bayer Enters CRISPR Field

Bayer Enters CRISPR Field

By | December 22, 2015

The pharmaceutical company will spend $335 million on a new venture with biotech startup CRISPR Therapeutics.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Sequencing Reveals Genomic Diversity of the Human Brain
  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech